We are live on ! Find out more
BJDX icon

Bluejay Diagnostics

5 hedge funds and large institutions have $119K invested in Bluejay Diagnostics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.13% more ownership

Funds ownership: 0.02%0.15% (+0.13%)

29% less funds holding

Funds holding: 75 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

66% less capital invested

Capital invested by funds: $345K → $119K (-$226K)

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AFM
1
Anson Funds Management
Texas
$48.6K +$292K +348 New
CH
2
CVI Holdings
Delaware
$46.3K +$278K +331 New
VF
3
Virtu Financial
New York
$12K +$65.5K +78 +1,114%
WAM
4
Warberg Asset Management
Illinois
$8.74K +$52.9K +63 New
TRCT
5
Tower Research Capital (TRC)
New York
$3.01K +$15.1K +18 +450%
SM
6
Sabby Management
Florida
-$150K -117 Closed
AC
7
Armistice Capital
New York
-$141K -110 Closed
Citadel Advisors
8
Citadel Advisors
Florida
-$15.9K -12 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
-$14K -11 Closed
XT
10
XTX Topco
Cayman Islands
-$8.43K -7 Closed
Osaic Holdings
11
Osaic Holdings
Arizona
-$20
Wells Fargo
12
Wells Fargo
California
-$8

BJDX Hedge Fund Activity: Q2 2024 in Review

5 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q2 2024, worth a combined $119K — down 66% from $345K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BJDX and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $292K. The largest seller was Sabby Management, exiting entirely with an estimated $150K sold.

  • 5 institutional investors held Bluejay Diagnostics (BJDX) as of Q2 2024, down from 7 in Q1 2024.
  • Funds reported $119K of Bluejay Diagnostics stock for Q2 2024, down 66% quarter-over-quarter.
  • 3 funds opened new Bluejay Diagnostics positions in Q2 2024 and 5 closed out, a net change of -2 holders.
  • The largest Bluejay Diagnostics buyer in Q2 2024 was Anson Funds Management, an estimated $292K added.
  • The largest Bluejay Diagnostics seller in Q2 2024 was Sabby Management, an estimated $150K sold.

Based on aggregated 13F filings for Q2 2024.